Today: 19 May 2026
Browse Category

OTC:GOVX 19 May 2026

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
19 May 2026
·

Stock Market Today

  • Nasdaq Futures Decline Amid Tech Sell-Off on May 19, 2026
    May 19, 2026, 7:05 AM EDT. Nasdaq futures fell sharply on May 19, 2026, driven by a significant sell-off in technology stocks. The decline reflects investor caution in the sector, impacting broader market sentiment. Meanwhile, geopolitical tensions linger as former President Trump announced he called off a planned attack on Iran, adding to the complex market environment. Traders are closely monitoring developments for further cues on market direction.

Latest articles

Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

19 May 2026
Standard Chartered will cut over 7,000 jobs by 2030 and aims for an 18% return on tangible equity, focusing on AI and automation to boost efficiency. The bank reported record Q1 operating income of $5.9 billion and profit before tax of $2.5 billion. Job cuts will mainly affect corporate and support roles in hubs like Bengaluru, Tianjin, and Warsaw. The bank seeks to attract $200 billion in new wealth by 2028.
AEP Stock Moves as 13F Filings Add More Questions

AEP Stock Moves as 13F Filings Add More Questions

19 May 2026
Institutional holdings in American Electric Power fell by March 31, with Northwestern Mutual Wealth Management, Allworth Financial, and Lockheed Martin Investment Management all reporting smaller stakes than at year-end. AEP raised its five-year capital plan to $78 billion this month, citing rising demand from data centers and industry. The company priced a 23.5 million share offering at $127 each after reporting first-quarter operating earnings of $1.64 per share.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Go toTop